POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL. Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist

Similar documents
Abnormal Uterine Bleeding Case Studies

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman

12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND

Polycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology

Conflicts 10/5/2016. Abnormal Uterine Bleeding. Objectives Review diagnosis and updated nomenclature. Management options for acute and chronic AUB.

2-Hypertrichosis:- Hypertrichosis is the

Polycystic Ovary Syndrome

Difference Between PCOS and Endometriosis

Chapter 100 Gynecologic Disorders

Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital

Case. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation

Polycystic Ovary Syndrome (PCOS):

Reproductive Testing: Less is More G. Wright Bates, Jr., M.D. Professor and Director Reproductive Endocrinology and Infertility Objectives

Polycystic Ovary Syndrome

Dr Mary Birdsall. Fertility Associates Auckland

Polycystic Ovarian Syndrome (PCOS) LOGO

POLYCYSTIC OVARIAN SYNDROME WHERE WE ARE AT IN 2018

Polycystic ovary syndrome

5/5/2010. Infertility FINANCIAL DISCLOSURE. Infertility Definition. Objectives. Normal Human Fertility. Normal Menstrual Cycle

What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...

Hormonal Control of Human Reproduction

SAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:

Topics. Periods Menopause & HRT Contraception Vulva problems

CLEAR COVERAGE HYSTERECTOMY CHECKLISTS

Infertility for the Primary Care Provider

PCOS and Obesity DUB is better treated by OCPs

Overview of Reproductive Endocrinology

Endometriosis. *Chocolate cyst in the ovary

Reproductive Health and Pituitary Disease

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

Adolescent Gynecology: Evaluation and Management of Adnexal Mass, PCOS, and Endometriosis. Shanna M. Combs, MD

INFERTILITY CAUSES. Basic evaluation of the female

F REQUENTLY A SKED Q UESTIONS

Polycystic Ovary Syndrome

Reproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands

Abnormal Uterine Bleeding: Evaluation of Premenopausal Women. Vanessa Jacoby, MD, MAS Assistant Professor Ob, Gyn, & Reproductive Sciences UCSF

Dysfunctional Uterine Bleeding (DUB) OB/GYN Hospital of Fudan University Weiwei Feng, MD,Ph D Tel:

Polycystic Ovary Syndrome

Amenorrhoea: polycystic ovary syndrome

lactotrophs 120 min- FSH 60 min- LH Hypothalamus GnRH pituitary Estradiol +/- Progesterone _ FSH L H Ovary Uterus Ovulation Antral follicle >2mm

Hyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)

9.4 Regulating the Reproductive System

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary

PCOS. Kirtly Parker Jones MD

Gynecologic Decision Making Based on Sonographic Findings

AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE

CASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?

Frequency of menses. Duration of menses 3 days to 7 days. Flow/amount of menses Average blood loss with menstruation is 60-80cc.

5/5/2010 FINANCIAL DISCLOSURE. Abnormal Uterine Bleeding. Is This A Problem? About me % of visits to gynecologist

Elaina Sexton, MD, MSc Obstetrics and Gynecology St. Vincent s Hospital. Objectives

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc)

OVERVIEW. FEMM (Fertility Education & Medical Management) is headquartered in New York City, NY. 1

1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.

Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre


Management of Gynae Problems in Primary Care David Griffiths FRCOG The Great Western Hospital Swindon. A brief overview

13 th Annual Women s Health Day PCOS. Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH

Month-Long Hormone Assessment: What goes up must come down. Disclaimer. Aims and Objectives. George Gillson MD PhD

Estrogens & Antiestrogens

PERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.

Approach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD

Disclosure. Outline. Obesity: Endocrine Issues as the Cause and as the Effect 4/5/2016

Progesterone, A Central Role in Hormone Balance and Cycle Control Today s Ignorance of Hormonal Importance:

Polycystic Ovary Syndrome (PCOS)

Chronic Pelvic Pain Case Study

Dr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO

Perimenopausal DUB. Mary Anne Jamieson, MD Associate Professor, OB/GYN Queen s University Kingston, Ontario

Female Reproductive System. Lesson 10

Prof.Dr. Nabil Lymon Head of Internal Medicine Department

Index. Note: Page numbers of article titles are in boldface type.

Abnormal Uterine Bleeding

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS

FEMALE PATIENT HISTORY

PCOS guidelines: What s relevant to general practice

MULTIPLE CHOICE: match the term(s) or description with the appropriate letter of the structure.

Management of Female infertility Tim Chang

On Diseases Of Menstruation And Ovarian READ ONLINE

Dysmenorrhoea Gynaecology د.شيماءعبداالميرالجميلي. Aetiology of secondary dysmenorrhea

10/24/2017. Financial Disclosure. Financial Disclosure

PCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION

UPDATE: Women s Health Issues

Female Reproductive Endocrinology

Polycystic Ovary Syndrome

FERTILITY & TCM. On line course provided by. Taught by Clara Cohen

Primary Care Gynaecology Guidelines: HEAVY REGULAR MENSTRUAL BLEEDING

Dysmenorrhea. Erin Eppsteiner, M.D. Department of Ob/Gyn The University of Iowa Roy J & Lucille A Carver College of Medicine

Polycystic Ovary Syndrome

Investigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle?

Infertility DR. RAHUL BEVARA

Palm Beach Obstetrics & Gynecology, PA

Clinical Problems in the Diagnosis and Treatment of PCOS During Adolescence

Dysfunctional Uterine Bleeding

Healthcare Education Research

MANAGEMENT OF REFRACTORY ENDOMETRIOSIS

Polycystic ovarian disease and Endometriosis

Infertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations

Pelvic Pain: Diagnosis and Management

The Impact of Insulin Resistance on Long-Term Health in PCOS

Transcription:

POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist

THE PILL Released to US market in 1960 10-15 x dose of hormones in HRT Over 10-14 million women use Works by blocking ovulation, affecting mucus for sperm migration, and endometrial thinning abortifacient effect

Pill Conditions Irregular bleeding Pain Endometriosis Polycystic Ovary Syndrome Acne Hirsutism Ovarian Cysts PMS Convenience

Pill Use Primary: as contraceptive-prevent life Alternative: natural family planning which uses natural physiologic markers to determine fertile time and then appropriately use to postpone or achieve pregnancy; no side effects; 98-99% effective; easy to learn; consistent with Catholic church teaching; enhances marriage; promotes love and life.

Normal Ovarian Cycle Phase 1: Follicular phase- estrogen dominant and prepares follicle for release and thickens endometrium; release of mucus Phase 2: Ovulation- release of egg, development of corpus luteum Phase 3: Luteal phase- progesterone dominant, elevation of temperature

Menstrual Cycle Day 1 is first day of bright red vaginal bleeding Cycles vary normally 21-35 days Some are anovulatory Usual length 3-7 days More variable in teens and perimenopause Regulated by feedback between ovary and pituitary, both positive and negative

Cooperative Progesterone Tx Progesterone vaginal capsules: 400-800 mg q hs q p+3-p+12; day 16-25 (does not interfere with charting) Crinone 8% (progesterone vag gel) one applicator q hs pv pz=3-p+12; day 16-25 Prometrium 200 mg (micronized progesterone) 1 caps q hs day 16-25 Other progestins, e.g. norithindrone

Pathologies to Consider Polycystic Ovary Syndrome Dysfunctional Uterine Bleeding Hirsutism Ovarian Cysts Dysmenorrhea

Polycystic Ovary Syndrome Hyperandrogenism Chronic Anovulation Insulin Resistance Must rule out adrenal hyperplasia, prolactin, androgen secreting tumor Unknown etiology, may be inborn error of metabolism

Insulin Resistance Leads to DM- 2-5 X risk Leads to obesity Leads to infertility Leads to cholesterol Leads to risk endometrial Cancer

Diagnosis PCOS Abnormal FSH/LH ratio Abnormal androgens; test total and free testosterone, DHEAS, TSH, Prolactin Fasting blood sugar, 2 hr GTT (75 gm), insulin levels 17 alpha OH progesterone US ovaries (not very reliable) Lipid profile

Treatment of PCOS Metformin: lowers insulin levels reduces androgen levels SHBG helps restore regular cycles increases effectiveness clomid 1500-2000 mg/day doses

Treatment of PCOS Pill: suppresses ovary, ovulation, creates pseudo pregnancy, lipids, SHBG androgens, regulates cycles There are no double-blinded placebo studies documenting superiority of treatment with pill, other than symptoms. No comparative studies.

Alternative Therapy Could cycle menses with cooperative progestin therapy; no down side Could treat hirsutism with topical creams, spironolactone, removal tx (laser) Could treat obesity with diet, exercise, lifestyle changes Infertility responds well to clomid

HIRSUTISM Idiopathic (no androgen excess) PCOS (common in about 50%) Congenital adrenal hyperplasia Cushing s syndrome Androgen secreting tumors Ethnicity

Evaluation Hx, physical exam, ethnic background Total and free testosterone DHEAS, Androstenedione Fasting 17 OH Progesterone TSH, Prolactin

Treatment Shaving, plucking, waxing, electrolysis Laser- permanent but expensive Vaniqua (temp. dihydrotestosterone antagonist) Spironolactone (200 mg /day) Pill not always successful Finasteride( 1-5 mg/day) Flutamide (250 mg/day)

Dysfunctional Uterine Bleeding Menses erratic, variable to 21 days or 35 days and sometimes lasting longer than 7 days and heavy with clotting. End of cycle brown discharge Heavier than pad q 2 hrs (saturated) Mid cycle bleeding Anemia Obesity (conversion of androgens to estrogens)

DUB TYPES Ovulatory: more common but with luteal phase deficiency-cycles usually shorter Anovulatory: less common with usually longer cycles Must rule out all other pathologypregnancy, cancer, fibroids, polyps, infections, foreign body (IUD), coagulopathy, thyroid disease? Tubal ligation syndrome

Evaluation CBC, platelets, PT, PTT, Factor V Leiden HCG, TSH, Prolactin, Endometrial biopsy Ultrasound Pap Cultures Physical exam and History

Treatment NSAID s Cooperative progesterone therapy Vitamins and Iron/Folate Exercise Acute bleeding- IV estrogen, 25 mg/4-6h Fluids, rest Endometrial ablation Progesterone (esp. norithindrone acetate) CAM- Magnesium, Chlorophyll, Cayenne

Goals of Treatment Relieve/alleviate acute bleeding Prevent further episodes of non-cyclic bleeding anemia Decrease pt s long term risk complications from anovulation, i.e. endometrial Cancer Improve overall quality of life

Ovarian Cysts Usually benign, self-limiting Normal physiologic- could be pathologic 200,000 hospitalizations annually Usually <5 cm= physiologic; >5cm possibly pathologic Types: simple, complex, hemorrhagic, dermoid, neoplasm

Symptoms Pain, acute onset- rupture Ovulatory- mittelschmerz May mimic acute AP, IBS, IC, Endo May be recurrent

Treatment Oral progesterone- needs high doses IM progesterone in oil- 200 mg IM Analgesics, rest, heat Rarely laparoscopy Usually resolves within 3 cycles May be recurrent Could consider Lupron chronic recurrence

Dysmenorrhea Painful menses with normal anatomy Lasts 1-3 days Severe in 15% adolescents Types: primary- physiologic-no other cause secondary- other pathologies, e.g. endometriosis, adenomyosis, dub/clots, cervical stenosis (post LEEP/cryo)

Differential Diagnosis Irritable bowel syndrome Interstitial cystitis Endometriosis/adenomyosis Psychogenic- sexual abuse Chronic PID

Treatment NSAID s Heat Exercise-aerobic- β endorphins Magnesium- 800-1000 mg/day Pain management Laparoscopy- Rule out other etiol.

Endometriosis Diagnosis by laparoscopy only Present in 33 % with chronic pelvic pain Occurs in 7-13% population 38 % infertile women

Etiology Unknown Retrograde menstruation Hematologic/lymphatic spread Is an estrogen dependent disease

Symptoms Secondary dysmenorrhea Chronic pelvic pain Dyspareunia Many asymptomatic

Treatment Medical: progestins, danocrine, GnRh agonists, pill Surgical: resection, cautery, laser, ablation Tx of choice= Lupron (poss. Add back); greater than 12 mos reversible bone loss

Summary Many reproductive dysfunctions currently treated by pill without appropriate scientific evidence that pill improves pathology; it just improves symptoms Symptom improvement not a bad thing..but, benefit must outweigh risk

Pill Side Effects Increased risk of blood clots Increased risk of phlebitis Increased risk of breast cancer Increased risk of heart attack, stroke Increased risk of liver tumors Increased risk of abnormal lipids Not physiologic; suppresses nl function, creates state of pseudo-pregnancy

Summary There ARE other methods of treatment Contraception is intrinsically evil One cannot do an evil to achieve a good IF one thinks pill is BEST tx for an individual, must look at circumstances re: sexual activity, abstinence, etc. Principle of double effect PRIMUM NON NOCERE